• E-TRAB: Geriatric Assessment of Elderly „Unsuited“ Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS); Zentren: Wien & Klagenfurt
  • Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised Phase III multicenter study by the Scandinavian Sarcoma Group
  • In preparation: An international, multicenter, open-label, randomized phase III Study of BLU-285 vs Regorafinib in patients with locally advanced unresectable or metastatic Gastrointestinal Stroma Tumor (GIST)
  • TAPPAS: A randomized phase III trial of TRC105 And Pazopanib versus Pazopanib alone in patients with advanced AngioSarcoma

Einen allgemeinen Überblick über Studien zu Sarkomen finden Sie hier: clinicaltrials